Chiara Vasco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chiara Vasco has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Emilio Ciusani
Laboratory of Neurological Biochemistry and Neuropharmacology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
8 shared publications - Jens Geginat
INGM, Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi” Milan Italy
7 shared publications Maurizio Zuccotti
Dipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali (S.Bi.Bi.T.), Sezione di Anatomia, Istologia ed Embriologia, University of Parma, Parma, Italy
5 shared publications- Andrea Salmaggi
Department of Neurology and Stroke Unit, ASST Lecco Ospedale Alessandro Manzoni, Lecco, Italy
4 shared publications Paola Larghi
INGM, Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi” Milan Italy
4 shared publicationsSergio Abrignani
INGM, Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi” Milan Italy
4 shared publications
Latest Publications
- Open Access
Autosomal Dominant Hyper‐ IgE Syndrome Patients Retain IL10 ‐Producing preTh17 ‐Cells That Are Activated by Opportunistic Pathogens and Support IgE Production
Background: Autosomal Dominant‐Hyper‐IgE Syndrome (AD‐HIES) is caused by dominant‐negative (DN) STAT3 mutations and characterized by high IgE levels, a lack of Th17‐cells, and recurrent infections with extracellular pathogens. We previously identified an enigmatic population of IL‐10 producing CCR6 + B‐helper T‐cells and investigated here their relationship to Th17‐cells and STAT3 signaling requirements. Methods: Human blood lymphocytes were analyzed by multiparametric flow cytometry in healthy donors and AD‐HIES patients. Analysis was performed by conventional gating or with bioinformatic tools. FACS‐purified T‐cell subsets were activated in vitro and Th17 differentiation assessed. T‐cell antigen specificities were assessed by activation with heat‐killed pathogens or antigenic peptide pools. B helper capacities were determined according to antibody secretion in B‐T co‐cultures by ELISA. Results: CCR6 + Th‐cells that lacked subset‐defining differentiation markers (“CCR6 SP ”) were mostly non‐polarized central memory T‐cells (T CM ) that produced IL‐10 and expressed RORγt. They were pre‐committed to a Th17 fate, since TCR stimulation in the absence of polarizing cytokines induced efficient Th17 differentiation. The latter was promoted by an autocrine loop of STAT3‐activating cytokines. CCR6 + Th‐cells were reduced in patients with DN‐STAT3 mutations but contained activated CCR6 SP T‐cells that produced IL‐10 and responded vigorously to AD‐HIES‐associated pathogens. These residual CCR6 + Th‐cells provided B‐cell help for IgG and IgE production. Conclusions: Th17 differentiation in AD‐HIES patients was not completely impaired but arrested at an intermediate stage of IL‐10‐producing “pre‐Th17”‐cells. Surprisingly, DN‐STAT3 mutations did not inhibit IL‐10 production by CD4 + T‐cells. Pre‐Th17‐cells were activated by AD‐HIES‐associated pathogens and possessed B‐helper functions, suggesting that they are not protective but may promote aberrant IgE production.
Open AccessAutosomal Dominant Hyper‐ IgE Syndrome Patients Retain IL10 ‐Producing preTh17 ‐Cells That Are Activated by Opportunistic Pathogens and Support IgE Production
Background: Autosomal Dominant‐Hyper‐IgE Syndrome (AD‐HIES) is caused by dominant‐negative (DN) STAT3 mutations and characterized by high IgE levels, a lack of Th17‐cells, and recurrent infections with extracellular pathogens. We previously identified an enigmatic population of IL‐10 producing CCR6 + B‐helper T‐cells and investigated here their relationship to Th17‐cells and STAT3 signaling requirements. Methods: Human blood lymphocytes were analyzed by multiparametric flow cytometry in healthy donors and AD‐HIES patients. Analysis was performed by conventional gating or with bioinformatic tools. FACS‐purified T‐cell subsets were activated in vitro and Th17 differentiation assessed. T‐cell antigen specificities were assessed by activation with heat‐killed pathogens or antigenic peptide pools. B helper capacities were determined according to antibody secretion in B‐T co‐cultures by ELISA. Results: CCR6 + Th‐cells that lacked subset‐defining differentiation markers (“CCR6 SP ”) were mostly non‐polarized central memory T‐cells (T CM ) that produced IL‐10 and expressed RORγt. They were pre‐committed to a Th17 fate, since TCR stimulation in the absence of polarizing cytokines induced efficient Th17 differentiation. The latter was promoted by an autocrine loop of STAT3‐activating cytokines. CCR6 + Th‐cells were reduced in patients with DN‐STAT3 mutations but contained activated CCR6 SP T‐cells that produced IL‐10 and responded vigorously to AD‐HIES‐associated pathogens. These residual CCR6 + Th‐cells provided B‐cell help for IgG and IgE production. Conclusions: Th17 differentiation in AD‐HIES patients was not completely impaired but arrested at an intermediate stage of IL‐10‐producing “pre‐Th17”‐cells. Surprisingly, DN‐STAT3 mutations did not inhibit IL‐10 production by CD4 + T‐cells. Pre‐Th17‐cells were activated by AD‐HIES‐associated pathogens and possessed B‐helper functions, suggesting that they are not protective but may promote aberrant IgE production.
- Open Access
Brain infiltrating T cells mediate microglial dysregulation and neuronal loss following SAH
The contribution of T cells to neuroinflammation after aneurysmal subarachnoid hemorrhage (SAH) remains poorly understood. Using a murine pre-chiasmatic injection model of SAH we demonstrate that T cell infiltration into the brain modulates microglial activation and promotes neuronal death. Targeted transcriptomic profiling revealed a sustained neuroimmune response at 7 days post injury (dpi) characterized by a major involvement of T cells and microglia activation. Immunohistochemistry confirmed focal CD3+ T cell infiltration, predominantly CD4+, in the brain at the site of blood injection (BI), choroid plexus and meninges in SAH mice at 3- and 7-dpi. This temporal pattern was also observed in the CSF of a human SAH cohort. T cell presence spatially correlated with regions of microglial reactivity and neuronal loss. Notably, CD3-knockout mice exhibited reduced microglial activation and preserved neuronal viability. These findings identify T cells as key amplifiers of post-SAH neuroinflammation and neuronal damage. Targeting T cell–microglia crosstalk may represent a novel therapeutic avenue for SAH. Summary statement: This study shows that brain T-cell infiltration after subarachnoid hemorrhage drives microglial activation and neuronal loss in mice, with similar patterns observed in patients. Data indicate T cells as key mediators of post-injury neuroinflammation with therapeutic implications.
Open AccessBrain infiltrating T cells mediate microglial dysregulation and neuronal loss following SAH
The contribution of T cells to neuroinflammation after aneurysmal subarachnoid hemorrhage (SAH) remains poorly understood. Using a murine pre-chiasmatic injection model of SAH we demonstrate that T cell infiltration into the brain modulates microglial activation and promotes neuronal death. Targeted transcriptomic profiling revealed a sustained neuroimmune response at 7 days post injury (dpi) characterized by a major involvement of T cells and microglia activation. Immunohistochemistry confirmed focal CD3+ T cell infiltration, predominantly CD4+, in the brain at the site of blood injection (BI), choroid plexus and meninges in SAH mice at 3- and 7-dpi. This temporal pattern was also observed in the CSF of a human SAH cohort. T cell presence spatially correlated with regions of microglial reactivity and neuronal loss. Notably, CD3-knockout mice exhibited reduced microglial activation and preserved neuronal viability. These findings identify T cells as key amplifiers of post-SAH neuroinflammation and neuronal damage. Targeting T cell–microglia crosstalk may represent a novel therapeutic avenue for SAH. Summary statement: This study shows that brain T-cell infiltration after subarachnoid hemorrhage drives microglial activation and neuronal loss in mice, with similar patterns observed in patients. Data indicate T cells as key mediators of post-injury neuroinflammation with therapeutic implications.
- Open Access
- 24 June 2025
- Published by Wiley
AD-HIES patients retain preTh17-cells that produce IL10 with opportunistic pathogens and induce IgE
11pt, fleqn, a4paper, ]LegrandOrangeBook Background Autosomal Dominant-Hyper-IgE Syndrome (AD-HIES) is caused by dominant-negative (DN) STAT3 mutations and characterized by high IgE levels, a lack of Th17-cells and recurrent infections with extracellular pathogens. We previously identified an enigmatic population of IL-10 producing CCR6 + B-helper T-cells and investigated here their relationship to Th17-cells and STAT3 signalling requirements. Methods Human blood lymphocytes were analysed by multiparametric flow cytometry in healthy donors and AD-HIES patients. Analysis was performed by conventional gating or with bioinformatic tools. FACS-purified T-cell subsets were activated in vitro and Th17 differentiation assessed. T-cell antigen specificities were assessed by activation with heat-killed pathogens or antigenic peptide pools. B helper capacities were determined according to antibody secretion in B-T co-cultures by ELISA. Results CCR6 + Th-cells that lacked subset-defining differentiation markers were mostly non-polarised central memory T-cells (T CM ) that produced IL-10 and expressed RORγt. They were pre-committed to a Th17 fate, since TCR stimulation in the absence of polarising cytokines induced efficient Th17 differentiation. The latter was promoted by an autocrine loop of STAT3-activating cytokines. CCR6 + Th-cells were reduced in patients with DN-STAT3 mutations but contained activated CCR6 + T CM that produced IL-10 and responded vigorously to AD-HIES-associated pathogens. These residual CCR6 + Th-cells provided B-cell help for IgG and IgE production. Conclusions Th17 differentiation in AD-HIES patients was not completely impaired but arrested at an intermediate stage of IL-10 producing “pre-Th17”-cells. Surprisingly, DN-STAT3 mutations did not inhibit IL-10 production by CD4 + T-cells. Pre-Th17-cells were activated by AD-HIES-associated pathogens and possessed B-helper functions, suggesting that they are not protective but promote aberrant IgE production.
- 24 June 2025
- Published by Wiley
Open AccessAD-HIES patients retain preTh17-cells that produce IL10 with opportunistic pathogens and induce IgE
11pt, fleqn, a4paper, ]LegrandOrangeBook Background Autosomal Dominant-Hyper-IgE Syndrome (AD-HIES) is caused by dominant-negative (DN) STAT3 mutations and characterized by high IgE levels, a lack of Th17-cells and recurrent infections with extracellular pathogens. We previously identified an enigmatic population of IL-10 producing CCR6 + B-helper T-cells and investigated here their relationship to Th17-cells and STAT3 signalling requirements. Methods Human blood lymphocytes were analysed by multiparametric flow cytometry in healthy donors and AD-HIES patients. Analysis was performed by conventional gating or with bioinformatic tools. FACS-purified T-cell subsets were activated in vitro and Th17 differentiation assessed. T-cell antigen specificities were assessed by activation with heat-killed pathogens or antigenic peptide pools. B helper capacities were determined according to antibody secretion in B-T co-cultures by ELISA. Results CCR6 + Th-cells that lacked subset-defining differentiation markers were mostly non-polarised central memory T-cells (T CM ) that produced IL-10 and expressed RORγt. They were pre-committed to a Th17 fate, since TCR stimulation in the absence of polarising cytokines induced efficient Th17 differentiation. The latter was promoted by an autocrine loop of STAT3-activating cytokines. CCR6 + Th-cells were reduced in patients with DN-STAT3 mutations but contained activated CCR6 + T CM that produced IL-10 and responded vigorously to AD-HIES-associated pathogens. These residual CCR6 + Th-cells provided B-cell help for IgG and IgE production. Conclusions Th17 differentiation in AD-HIES patients was not completely impaired but arrested at an intermediate stage of IL-10 producing “pre-Th17”-cells. Surprisingly, DN-STAT3 mutations did not inhibit IL-10 production by CD4 + T-cells. Pre-Th17-cells were activated by AD-HIES-associated pathogens and possessed B-helper functions, suggesting that they are not protective but promote aberrant IgE production.
- Open Access
AD-HIES patients retain preTh17-cells that produce IL10 with opportunistic pathogens and induce IgE
Background: Autosomal Dominant-Hyper-IgE Syndrome (AD-HIES) is caused by dominant-negative (DN) STAT3 mutations and characterized by high IgE levels, a lack of Th17-cells and recurrent infections with extracellular pathogens. We previously identified an enigmatic population of IL-10 producing CCR6 + B-helper T-cells and investigated here their relationship to Th17-cells and STAT3 signalling requirements. Methods: Human blood lymphocytes were analysed by multiparametric flow cytometry in healthy donors and AD-HIES patients. Analysis was performed by conventional gating or with bioinformatic tools. FACS-purified T-cell subsets were activated in vitro and Th17 differentiation assessed. T-cell antigen specificities were assessed by activation with heat-killed pathogens or antigenic peptide pools. B helper capacities were determined according to antibody secretion in B-T co-cultures by ELISA. Results: CCR6 + Th-cells that lacked subset-defining differentiation markers were mostly non-polarised central memory T-cells (T CM ) that produced IL-10 and expressed RORγt. They were pre-committed to a Th17 fate, since TCR stimulation in the absence of polarising cytokines induced efficient Th17 differentiation. The latter was promoted by an autocrine loop of STAT3-activating cytokines. CCR6 + Th-cells were reduced in patients with DN-STAT3 mutations but contained activated CCR6 + T CM that produced IL-10 and responded vigorously to AD-HIES-associated pathogens. These residual CCR6 + Th-cells provided B-cell help for IgG and IgE production. Conclusions: Th17 differentiation in AD-HIES patients was not completely impaired but arrested at an intermediate stage of IL-10 producing “pre-Th17”-cells. Surprisingly, DN-STAT3 mutations did not inhibit IL-10 production by CD4 + T-cells. Pre-Th17-cells were activated by AD-HIES-associated pathogens and possessed B-helper functions, suggesting that they are not protective but promote aberrant IgE production.
Open AccessAD-HIES patients retain preTh17-cells that produce IL10 with opportunistic pathogens and induce IgE
Background: Autosomal Dominant-Hyper-IgE Syndrome (AD-HIES) is caused by dominant-negative (DN) STAT3 mutations and characterized by high IgE levels, a lack of Th17-cells and recurrent infections with extracellular pathogens. We previously identified an enigmatic population of IL-10 producing CCR6 + B-helper T-cells and investigated here their relationship to Th17-cells and STAT3 signalling requirements. Methods: Human blood lymphocytes were analysed by multiparametric flow cytometry in healthy donors and AD-HIES patients. Analysis was performed by conventional gating or with bioinformatic tools. FACS-purified T-cell subsets were activated in vitro and Th17 differentiation assessed. T-cell antigen specificities were assessed by activation with heat-killed pathogens or antigenic peptide pools. B helper capacities were determined according to antibody secretion in B-T co-cultures by ELISA. Results: CCR6 + Th-cells that lacked subset-defining differentiation markers were mostly non-polarised central memory T-cells (T CM ) that produced IL-10 and expressed RORγt. They were pre-committed to a Th17 fate, since TCR stimulation in the absence of polarising cytokines induced efficient Th17 differentiation. The latter was promoted by an autocrine loop of STAT3-activating cytokines. CCR6 + Th-cells were reduced in patients with DN-STAT3 mutations but contained activated CCR6 + T CM that produced IL-10 and responded vigorously to AD-HIES-associated pathogens. These residual CCR6 + Th-cells provided B-cell help for IgG and IgE production. Conclusions: Th17 differentiation in AD-HIES patients was not completely impaired but arrested at an intermediate stage of IL-10 producing “pre-Th17”-cells. Surprisingly, DN-STAT3 mutations did not inhibit IL-10 production by CD4 + T-cells. Pre-Th17-cells were activated by AD-HIES-associated pathogens and possessed B-helper functions, suggesting that they are not protective but promote aberrant IgE production.
- Open Access
Regulatory T-cells in multiple sclerosis produce IL-10 in the central 1 nervous system but are activated by Epstein-Barr Virus
Regulatory T-cells (Tregs) maintain immune homeostasis, but antigens activating adaptive Tregs in human pathologies are ill-defined. EOMES + type-1 regulatory (Tr1)-like T-cells had a dysregulated homeostasis in multiple sclerosis (MS), which was related to their activation in the central nervous system (CNS). EOMES + Tr1-like cells were enriched and clonally expanded in patient’s cerebrospinal fluid (CSF) and were the major IL-10-producing T-cell subset in the CNS. Regulatory T-cells from PwMS produced IL-10 and IFN-γ with antigens derived from Epstein-Barr Virus (EBV), but not from myelin. EOMES + Tr1-like cells responded selectively to the latency-associated antigen EBNA1, whereas FOXP3 + Tregs and Th1-cells responded also to lytic EBV antigens. EBNA1-specific EOMES + Tr1-like cells were present in patients carrying the HLA-DRB1*15:01 risk allele, were associated with anti-EBNA1 IgG and disappeared upon therapeutic B-cell depletion. IL-10 + EOMES + Tr1-like were present in MS brain lesions, and some were in the vicinity of EBV-infected B-cells and CD8 + T-cells. Notably, EOMES + Tr1-like cells suppressed CD8+T-cell activation by EBV-infected B-cells. We propose that the insufficient protective functions of Tregs in MS are due to their aberrant anti-viral specificities that promote immune escape of a disease-associated virus.
Open AccessRegulatory T-cells in multiple sclerosis produce IL-10 in the central 1 nervous system but are activated by Epstein-Barr Virus
Regulatory T-cells (Tregs) maintain immune homeostasis, but antigens activating adaptive Tregs in human pathologies are ill-defined. EOMES + type-1 regulatory (Tr1)-like T-cells had a dysregulated homeostasis in multiple sclerosis (MS), which was related to their activation in the central nervous system (CNS). EOMES + Tr1-like cells were enriched and clonally expanded in patient’s cerebrospinal fluid (CSF) and were the major IL-10-producing T-cell subset in the CNS. Regulatory T-cells from PwMS produced IL-10 and IFN-γ with antigens derived from Epstein-Barr Virus (EBV), but not from myelin. EOMES + Tr1-like cells responded selectively to the latency-associated antigen EBNA1, whereas FOXP3 + Tregs and Th1-cells responded also to lytic EBV antigens. EBNA1-specific EOMES + Tr1-like cells were present in patients carrying the HLA-DRB1*15:01 risk allele, were associated with anti-EBNA1 IgG and disappeared upon therapeutic B-cell depletion. IL-10 + EOMES + Tr1-like were present in MS brain lesions, and some were in the vicinity of EBV-infected B-cells and CD8 + T-cells. Notably, EOMES + Tr1-like cells suppressed CD8+T-cell activation by EBV-infected B-cells. We propose that the insufficient protective functions of Tregs in MS are due to their aberrant anti-viral specificities that promote immune escape of a disease-associated virus.
- 1 February 2024
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 70 (2) , 146-148
Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs
- 1 February 2024
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 70 (2) , 146-148
Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs
- Open Access
The Role of Adhesion Molecules and Extracellular Vesicles in an In Vitro Model of the Blood–Brain Barrier for Metastatic Disease
Metastatic brain disease (MBD) has seen major advances in clinical management, focal radiation therapy approaches and knowledge of biological factors leading to improved prognosis. Extracellular vesicles (EVs) have been found to play a role in tumor cross-talk with the target organ, contributing to the formation of a premetastatic niche. Human lung and breast cancer cell lines were characterized for adhesion molecule expression and used to evaluate their migration ability in an in vitro model. Conditioned culture media and isolated EVs, characterized by super resolution and electron microscopy, were tested to evaluate their pro-apoptotic properties on human umbilical vein endothelial cells (HUVECs) and human cerebral microvascular endothelial cells (HCMEC/D3) by annexin V binding assay. Our data showed a direct correlation between expression of ICAM1, ICAM2, β3-integrin and α2-integrin and the ability to firmly adhere to the blood–brain barrier (BBB) model, whereas the same molecules were down-regulated at a later step. Extracellular vesicles released by tumor cell lines were shown to be able to induce apoptosis in HUVEC while brain endothelial cells showed to be more resistant.
Open AccessThe Role of Adhesion Molecules and Extracellular Vesicles in an In Vitro Model of the Blood–Brain Barrier for Metastatic Disease
Metastatic brain disease (MBD) has seen major advances in clinical management, focal radiation therapy approaches and knowledge of biological factors leading to improved prognosis. Extracellular vesicles (EVs) have been found to play a role in tumor cross-talk with the target organ, contributing to the formation of a premetastatic niche. Human lung and breast cancer cell lines were characterized for adhesion molecule expression and used to evaluate their migration ability in an in vitro model. Conditioned culture media and isolated EVs, characterized by super resolution and electron microscopy, were tested to evaluate their pro-apoptotic properties on human umbilical vein endothelial cells (HUVECs) and human cerebral microvascular endothelial cells (HCMEC/D3) by annexin V binding assay. Our data showed a direct correlation between expression of ICAM1, ICAM2, β3-integrin and α2-integrin and the ability to firmly adhere to the blood–brain barrier (BBB) model, whereas the same molecules were down-regulated at a later step. Extracellular vesicles released by tumor cell lines were shown to be able to induce apoptosis in HUVEC while brain endothelial cells showed to be more resistant.
- 21 September 2020
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 73 (11-12) , 2315-2322
MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet
Glioblastoma multiforme (GBM) is considered the most malignant form of primary brain tumor. Despite multimodal treatment, prognosis remains poor. Ketogenic diet (KD) has been suggested for the treatment of GBM. In this study, the syngenic, orthotopic GL261 mouse glioma model was used to evaluate the effects of KD on the metabolic responses of the tumor using 7T magnetic resonance imaging/spectroscopy. GL261 cells were injected into the caudate nucleus of mice. Following implantation, animals were fed with standard chow or underwent a KD. 18 days after initiating the diet, mice fed with KD displayed significantly higher plasmatic levels of ketone bodies and survived longer than those fed with the standard diet. Decreased concentrations of gamma-aminobutyric acid, N-Acetyl-Aspartate and N-acetylaspartylglutamate were found in tumor tissue after 9 days into the KD, while a huge increase in beta-hydroxybutyrate (bHB) was detected in tumor tissue as compared to normal brain. The accumulation of bHB in the tumor tissue in mice undergoing the KD, may suggest either elevated uptake/release of bHB by tumor cells, or the inability of tumor cells in this context to use it for mitochondrial metabolism.
- 21 September 2020
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 73 (11-12) , 2315-2322
MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet
Glioblastoma multiforme (GBM) is considered the most malignant form of primary brain tumor. Despite multimodal treatment, prognosis remains poor. Ketogenic diet (KD) has been suggested for the treatment of GBM. In this study, the syngenic, orthotopic GL261 mouse glioma model was used to evaluate the effects of KD on the metabolic responses of the tumor using 7T magnetic resonance imaging/spectroscopy. GL261 cells were injected into the caudate nucleus of mice. Following implantation, animals were fed with standard chow or underwent a KD. 18 days after initiating the diet, mice fed with KD displayed significantly higher plasmatic levels of ketone bodies and survived longer than those fed with the standard diet. Decreased concentrations of gamma-aminobutyric acid, N-Acetyl-Aspartate and N-acetylaspartylglutamate were found in tumor tissue after 9 days into the KD, while a huge increase in beta-hydroxybutyrate (bHB) was detected in tumor tissue as compared to normal brain. The accumulation of bHB in the tumor tissue in mice undergoing the KD, may suggest either elevated uptake/release of bHB by tumor cells, or the inability of tumor cells in this context to use it for mitochondrial metabolism.
- Open Access
- 14 August 2019
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-15
Adipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities
Mesenchymal stem cells (MSCs) are multipotent cells able to differentiate into multiple cell types, including adipocytes, osteoblasts, and chondrocytes. The role of adipose-derived stem cells (ADSCs) in cancers is significantly relevant. They seem to be involved in the promotion of tumour development and progression and relapse processes. For this reason, investigating the effects of breast cancer microenvironment on ADSCs is of high importance in order to understand the relationship between tumour cells and the surrounding stromal cells. With the current study, we aimed to investigate the specific characteristics of human ADSCs isolated from the adipose tissue of breast tumour patients. We compared ADSCs obtained from periumbilical fat (PF) of controls with ADSCs obtained from adipose tissue of breast cancer- (BC-) bearing patients. We analysed the surface antigens and the adipogenic differentiation ability of both ADSC populations. C/EBPδ expression was increased in PF and BC ADSCs induced to differentiate compared to the control while PPARγ and FABP4 expressions were enhanced only in PF ADSCs. Conversely, adiponectin expression was reduced in PF-differentiated ADSCs while it was slightly increased in differentiated BC ADSCs. By means of Oil Red O staining, we further observed an impaired differentiation capability of BC ADSCs. To investigate this aspect more in depth, we evaluated the effect of selective PPARγ activation and nutritional supplementation on the differentiation efficiency of BC ADSCs, noting that it was only with a strong differentiation stimuli that the process took place. Furthermore, we observed no response in BC ADSCs to the PPARγ inhibitor T0070907, showing an impaired activation of this receptor in adipose cells surrounding the breast cancer microenvironment. In conclusion, our study shows an impaired adipogenic differentiation capability in BC ADSCs. This suggests that the tumour microenvironment plays a key role in the modulation of the adipose microenvironment located in the surrounding tissue.
- 14 August 2019
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-15
Open AccessAdipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities
Mesenchymal stem cells (MSCs) are multipotent cells able to differentiate into multiple cell types, including adipocytes, osteoblasts, and chondrocytes. The role of adipose-derived stem cells (ADSCs) in cancers is significantly relevant. They seem to be involved in the promotion of tumour development and progression and relapse processes. For this reason, investigating the effects of breast cancer microenvironment on ADSCs is of high importance in order to understand the relationship between tumour cells and the surrounding stromal cells. With the current study, we aimed to investigate the specific characteristics of human ADSCs isolated from the adipose tissue of breast tumour patients. We compared ADSCs obtained from periumbilical fat (PF) of controls with ADSCs obtained from adipose tissue of breast cancer- (BC-) bearing patients. We analysed the surface antigens and the adipogenic differentiation ability of both ADSC populations. C/EBPδ expression was increased in PF and BC ADSCs induced to differentiate compared to the control while PPARγ and FABP4 expressions were enhanced only in PF ADSCs. Conversely, adiponectin expression was reduced in PF-differentiated ADSCs while it was slightly increased in differentiated BC ADSCs. By means of Oil Red O staining, we further observed an impaired differentiation capability of BC ADSCs. To investigate this aspect more in depth, we evaluated the effect of selective PPARγ activation and nutritional supplementation on the differentiation efficiency of BC ADSCs, noting that it was only with a strong differentiation stimuli that the process took place. Furthermore, we observed no response in BC ADSCs to the PPARγ inhibitor T0070907, showing an impaired activation of this receptor in adipose cells surrounding the breast cancer microenvironment. In conclusion, our study shows an impaired adipogenic differentiation capability in BC ADSCs. This suggests that the tumour microenvironment plays a key role in the modulation of the adipose microenvironment located in the surrounding tissue.
- 1 November 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 142 (5) , 1537-1547.e8
Intestinal IFN-γ–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease
- 1 November 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 142 (5) , 1537-1547.e8
Intestinal IFN-γ–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease